Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Product/R&D News
Bio-Thera's IND for Biosimilar of Stelara (Ustekinumab) Approved ... 12/4/2019
Hanmi's Chinese Partner to Start Trials for Anticancer Treatment 11/29/2019
UK and China Research Team Take First Steps Towards A Vaccine for... 11/26/2019
Chi-Med's Surufatinib Granted Orphan Drug Designation by the USFD... 11/26/2019
NMPA Approves IND Application of MDI for Analgesic Penthrox 11/21/2019
LIDDS licensee Jiangxi Puheng Pharma Prepares for Phase III Trial... (free) 11/20/2019
RemeGen Announces Positive Results from Phase IIb Trial of SLE Dr... 11/16/2019
CDE Accepts Lilly's NDA for Verzenio (Abemaciclib) 11/15/2019
U.S. FDA Grants BeiGene's BRUKINSA (zanubrutinib) Accelerated App... 11/15/2019
Hua Medicine's Pivotal Phase III Monotherapy Trial of Dorzagliati... 11/13/2019
Chi-Med Announces NDA Acceptance for Novel Drug Surufatinib 11/11/2019
Akesobio Presents P1 Data from First-in-class Bispecific Drug Can... 11/11/2019
VISEN Announces China Phase 3 Clinical Study Initiation for Trans... 11/5/2019
NMPA Approves the World's First Seaweed-based Alzheimer's Drug 11/4/2019
Terns Pharma Receives USFDA Fast Track Designation for TERN-101 10/30/2019
Snapshot of Chinese Clinical Trials by Regional Distribution 10/25/2019
Yifan's Transplant Rejection Reversal Drug Gets Orphan Drug Statu... 10/24/2019
Shionogi’s Thrombopoietin Receptor Agonist Lusutrombopag Granted... 10/14/2019
Harbour BioMed Completes Phase 2 Chinese Study of HBM9036 for Dry... 10/14/2019
CBMG Builds R&D Center in MD as Its ReJoin Stem Cell Therapy Acce... (free) 10/3/2019
NMPA Approves IND for Fully-human BCMA CAR-T 10/3/2019
Mitsubishi Tanabe Files for Tenelia (Teneligliptin) Approval in C... 9/24/2019
Xynomic Pharma Wins FDA Fast-Track Designation of Abexinostat for... 9/23/2019
Clinical Investigation Begins for China-developed Novel Chronic P... 9/20/2019
MicuRx Reports Positive Top-line Results of a China Phase 3 Trial... 9/20/2019
ASLAN Pharma Presents China Phase 2 Data for Varlitinib in Second... 9/19/2019
CASI Announces NMPA Acceptance of Its Clinical Trial Application ... 9/17/2019
Hansoh Atomwise Launch Strategic AI Drug Discovery Collaboration ... 9/11/2019
Athenex Announces Initiation of Phase I Trial in China of KX2-361... 9/11/2019
Xynomic Pharma Reports Encouraging Data on Lead Cancer Drug 8/30/2019
Page:1/4    Total number of articles:104  :[1][2][3][4]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links